Biosensors Intl Grp (BSNRF) 0.5964 $BSNRF Global

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biosensors Intl Grp (BSNRF) 0.5964 $BSNRF

Global Biochemical Sensors Market Forecast and Opportunities 2015-2020
M2 - Fri May 08, 9:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ctbmsf/global) has announced the addition of the "Global Biochemical Sensors Market Forecast and Opportunities, 2020" report to their offering. The global biochemical sensors market is projected to reach USD23.3 billion by 2020 Electrochemical, optical, thermal, and piezoelectric are the major types of biochemical sensors used across diverse applications. Growing health concerns, declining cost of devices coupled with miniaturization of biochemical sensing devices are few of the major factors expected to drive demand for biochemical sensors over the next five years. High accuracy, easy usability, higher sensitivity even at low analyte concentrations are boosting the adoption of biochemical sensors across diverse end use applications. Growing need for low-cost, easy to use, fast and reliable analytical tools has been paving the way for use of biochemical sensors for quantitative and qualitative determination of discrete analytes in clinical, agricultural, environmental, food and defense applications. Presently, biochemical sensors are being predominantly used in medical applications, however, their adoption is increasing in agricultural, nutritional and environmental sectors due to continuous emphasis on improving product quality and growing need to comply with legislative guidelines. Increasing research & development activities, rising government emphasis and increasing advancements in healthcare infrastructure are expected to drive the sales of biochemical sensors over next five years. Global Biochemical Sensors Market Forecast & Opportunities, 2020 discusses the following aspects about the global biochemical sensors market: - Global Biochemical Sensors Market Size, Share & Forecast - Segmental Analysis - By Product Type (Electro-chemical, Thermal, Piezoelectic, Optical, etc.) and By End Use (Medical, Environmental, Nutritional & Agricultural) - Regional Analysis (North America, Europe, Asia-Pacific & Rest of World) - Changing Market Trends & Emerging Opportunities - Competitive Landscape & Strategic Recommendations Market Trends & Developments - Development of Silicon Microsensors - Development of Optical Fibers - Automotive Biochemical Sensors Technology - Growing Demand of Personalized Medicine - Miniaturization of Biochemical sensors - Integration of Wireless Communications Systems - Mass Production of Biochemical sensors Competitive Landscape - Company Shares - Abbott Point of Care Inc - Smiths Medical Md, Inc - LifeSensors Inc - LifeScan Inc. - Medtronic plc - Boston Scientific Corporation - Nova Biomedical Corporation - Acon Laboratories, Inc - Bio-Rad Laboratories, Inc - Universal Biosensors, Inc - Bayer AG - Pharmaco-Kinesis Corporation - SensLab - BioDetection Instruments, Inc - Biosensor Laboratories Incorporated - ABTECH Scientific, Inc - NeuroSky, Inc. - Biosensors International Group, Ltd - Roche Diagnostics - Sysmex Corporation - YSI Life Sciences For more information visit http://www.researchandmarkets.com/research/ctbmsf/global
BSX: 17.85 (-0.06), MDT: 76.42 (+0.16)

Global Drug Eluting Stents (DES) Pipeline Review 2015
M2 - Tue Apr 28, 3:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/k44d7d/drug_eluting) has announced the addition of the "Drug Eluting Stents (DES) - Pipeline Review, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key drug eluting stents pipeline products. Scope: - Extensive coverage of the Drug Eluting Stents products under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Drug Eluting Stents and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry The report enables you to: - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of Drug Eluting Stents under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the product's current stage of development, territory and estimated launch date Companies Featured: - Abbott Vascular Inc. - AlviMedica Medical Technologies Inc. - Amaranth Medical, Inc. - Arterius Ltd - Biosensors International Group, Ltd. - BioSurfaces, Inc. - Biotronik SE & Co. KG - Boston Scientific Corporation - CARDIONOVUM GmbH - CID S.r.l. - Contego Medical, LLC - DISA Vascular (Pty) Ltd. - Elixir Medical Corporation - Envision Scientific Pvt. Ltd - Eurocor GmbH - HangZhou HuaAn Biotechnology Co.,Ltd - Icon Interventional Systems, Inc. - ICON Medical Corp. - InspireMD, Inc. - IRAMED GmbH - Lepu Medical Technology (Beijing) Co., Ltd. - Medinol Ltd. - Medtronic plc - Meril Life Sciences Pvt. Ltd. - Micell Technologies, Inc. - Minvasys - NanoCoeur, Inc. - Northwestern University - OrbusNeich - REVA Medical, Inc. For more information visit http://www.researchandmarkets.com/research/k4...ug_eluting
BSX: 17.85 (-0.06), MDT: 76.42 (+0.16), NSPR: 0.20 (unch)

Leading 100 Medical Devices/Technology/Supplies Companies of Emerging Markets 2015
M2 - Wed Apr 15, 7:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w5kc32/emerging_markets) has announced the addition of the "Emerging Markets Medical Devices/Technology/Supplies 100: An Industry Report" report to their offering. Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and rehabilitation process. Emerging markets are widely recognized as one of the most important growth frontiers for medical devices. The healthcare industry has long seen that emerging markets have great untapped potential. In recent years many medical device companies have also begun to realize this potential and shift not only manufacturing but research and development to these emerging economies. The medical devices industry has exhausted its market territory in North America and Europe. Thus it is looking to expand into emerging markets which have shown promise due to increased demand for the healthcare industry, by the ageing population. Emerging markets are now considered one of the most important areas for growth for medical devices market. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the Emerging Markets companies in the medical industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices/technology/supplies companies of Emerging Markets - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among Emerging Markets medical devices/technology/supplies companies - International presence of Emerging Markets medical devices/technology/supplies companies - R&D activities by Emerging Markets medical devices/technology/supplies companies Key Topics Covered: 1. Rankings of Emerging Markets Medical Devices/Technology/Supplies Companies 2. Stock Market Performance over 5 Years. Leading 25 Emerging Markets Medical Devices/Technology/Supplies Companies 3. Key News of Emerging Markets Medical Devices/Technology/Supplies Companies for Year 2014 4. Important Alliances among Emerging Markets Medical Devices/Technology/Supplies Companies 5. International Presence of Emerging Markets Medical Devices/Technology/Supplies Companies 6. Research and Development Activities by Emerging Markets Medical Devices/Technology/Supplies Companies 7. Mergers and Acquisitions among Emerging Markets Medical Devices/Technology/Supplies Companies Companies Mentioned (Partial List) - Advanced Technology Company (Kuwait) - Biosensors International Group Ltd (Singapore) - CPC Diagnostics Pvt. Ltd (India) - Enjoyor Co., Ltd. (China) - Excelsior Medical Company Limited (Taiwan) - Ginko International Co Ltd (Taiwan) - Guangdong Shirongzhaoye Co Ltd (China) - Kossan Rubber Industries Berhad (Malaysia) - Largan Precision Company Limited (Taiwan) - MediVed Innovations Private Limited (India) - Mindray Medical International Limited (China) - Ningbo David Medical Device Co Ltd (China) - Optics India Equipments Private Limited (India) - Phoenix Medical Systems Private Limited (India) - Pneumo Care Health Private Limited (India) - PT Perdana Bangun Pusaka (Konica) Tbk (Indonesia) - PW Medtech Group Ltd (Hong Kong) - Remi Elektrotechnik Ltd. (India) - Sekonix Co Ltd (South Korea) - Servo-Med Industries Private Limited (India) - Shandong Pharmaceutical Glass Co Ltd (China) - Shandong Weigao Group Medical Polymer Co Ltd (Hong Kong) - Shanghai Tofflon Science and Technology Co Ltd (China) - South India Surgical Company Ltd (India) - Spectro Lab Equipments Pvt Ltd (India) - Syneron Medical Ltd. (Israel) - Toshvin Analytical Private Ltd (India) - Vimta Labs Ltd. (India) - Vinjoh Healthcare Private Limited (India) - Wadegati Labequip Private Limited (India) For more information visit http://www.researchandmarkets.com/research/w5...ng_markets
ELOS: 11.76 (-0.19), MR: 27.56 (+0.07)

Top 100 Asia Medical Devices/Technology/Supplies Companies 2015
M2 - Tue Apr 07, 4:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wttv9s/asia_medical) has announced the addition of the "Asia Medical Devices/Technology/Supplies 100: An Industry Report" report to their offering. Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and rehabilitation process. Medical device companies remain bullish about Asian markets, driven by ageing populations, growing middle classes and government investments in healthcare. Strong demand for Asian medical devices has delivered sales growth of 44.1% compared to North/South America and Europe/Middle East/Africa. In 2012, the total value of the ASEAN medical device market was more than US $4 billion and the value is expected to increase to US $8 billion by 2017. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the Asian companies in the medical industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices/technology/supplies companies of Asia - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among Asian medical devices/technology/supplies companies - International presence of Asian medical devices/technology/supplies companies - R&D activities by Asian medical devices/technology/supplies companies Key Topics Covered: 1. Rankings of Asian Medical Devices/Technology/Supplies Companies 2. Stock Market Performance over 5 Years. Leading 25 Asian Medical Devices/Technology/Supplies Companies 3. Key News of Asian Medical Devices/Technology/Supplies Companies for Year 2014 4. Important Alliances among Asian Medical Devices/Technology/Supplies Companies 5. International Presence of Asian Medical Devices/Technology/Supplies Companies 6. Research and Development Activities by Asian Medical Devices/Technology/Supplies Companies 7. Mergers and Acquisitions among Asian Medical Devices/Technology/Supplies Companies Companies Mentioned - Partial List - Alfresa Pharma Corp (Japan) - Ansell Limited (Australia) - Arts Optical International Holdings Limited (Hong Kong) - AS ONE CORPORATION (Japan) - Asahi Intecc Co., Ltd. (Japan) - Beijing Wandong Medical Equipment Co. Ltd. (China) - Biosensors International Group Ltd (Singapore) - Blue Sail Medical Co Ltd (China) - CHC Healthcare Group (Taiwan) - China Medical System Hldgs Ltd (Hong Kong) - China Medicine Health Industry Co. Ltd (China) - China National Medicines Corp Ltd (China) - Citadel Research And Solutions Private Limited (India) - Claris Lifesciences Ltd. (India) - Cochlear Limited (Australia) - Confident Dental Equipments Limited (India) - Da An Gene Co Ltd of Sun Yat-Sen University (China) - Dipped Products Plc (Sri Lanka) - Ebos Group Limited (New Zealand) - Enjoyor Co., Ltd. (China) For more information visit http://www.researchandmarkets.com/research/wt...ia_medical

Top 100 Global Medical Devices/Technology/Supplies Not Active in India 2015
M2 - Thu Apr 02, 8:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dgm6pr/global_medical) has announced the addition of the "Global Medical Devices/Technology/Supplies Not Active in India 100" report to their offering. The global size of the medical devices sector is predicted to reach US $400 billion this year. However, India - a key player in the global pharmaceuticals industry, of which medical devices used to be covered - is underperforming. The country's market share stood at US $6.3 billion in 2013, contributing around 7-8 percent to overall healthcare spending in India as opposed to the 18 percent contributed by pharmaceuticals. With per capita spending estimated to be at less than US $3, it is understandable that the government feels FDI is the only way to spur domestic growth. Despite such figures, India's medical devices sector is expected to experience unprecedented growth during the next decade. By 2025, the industry is projected to be worth US $50 billion. This can be attributed to the country's growing middle class, an increase in the number of hospitals and, consequently, a greater need for sophisticated medical devices and better healthcare. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the global companies in the medical devices/technology/supplies industry, which they would find beneficial to pursue for making business decisions in this sector in India. Highlights: - Leading global 100 medical devices/technology/supplies companies with no presence in India - Integration of company news and industry news, as well as rankings - Important M&A and alliances among global medical devices/technology/supplies companies not active in India - International presence of global medical devices/technology/supplies companies not active in India - R&D activities by global medical devices/technology/supplies companies not active in India Key Topics Covered: 1: Rankings of Global Medical Devices/Technology/Supplies Companies Not Doing Business in India News Section: 2: Key News of Global Medical Devices/Technology/Supplies Companies Not Doing Business in India for Year 2014 3: Alliances among Global Medical Devices/Technology/Supplies Companies Not Doing Business in India 4: International Presence of Global Medical Devices/Technology/Supplies Companies Not Doing Business in India 5: Research and Development Activities by Global Medical Devices/Technology/Supplies Companies Not Doing Business in India 6: Mergers and Acquisitions among Global Medical Devices/Technology/Supplies Companies Not Doing Business in India Companies Mentioned: Partial List - Abaxis Inc (United States) - Abiomed, Inc. (United States) - Advanced Technology Company (Kuwait) - Align Technology, Inc. (United States) - American Science and Engineering, Inc. (United States) - Angiodynamics, Inc. (United States) - Ansell Limited (Australia) - Arseus NV (Belgium) - Arts Optical International Holdings Limited (Hong Kong) - Atrion Corporation (United States) - Austar Lifesciences Ltd (Hong Kong) - Bastide le Confort Medical (France) - Biosensors International Group Ltd (Singapore) - Cantel Medical Corp. (United States) - China Medicine Health Industry Co. Ltd (China) - China National Medicines Corp Ltd (China) - Cooper Companies Inc (United States) - Create Medic Co., Ltd. (Japan) - Cremer SA (Brazil) - Cryolife, Inc. (United States) For more information visit http://www.researchandmarkets.com/research/dg...al_medical
ALGN: 59.28 (-0.03), ABAX: 52.74 (-0.01), ASEI: 39.97 (+0.01), CMN: 46.66 (-0.73), COO: 180.98 (+0.20)

CREDIT II Stent Trial Completes Enrollment
PR Newswire - Wed Mar 11, 7:59AM CDT
JW Medical Systems Limited ("JWMS" , a fully-owned subsidiary of Biosensors International Group, Ltd. ("Biosensors" or the "Company" (Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), has announced completion of patient enrollment in CREDIT II, the first randomized controlled trial ("RCT" involving the EXCEL II coronary stent. EXCEL II is the latest generation in the EXCEL family of biodegradable polymer drug-eluting stents ("BP-DES" , the leading BP-DES brand in China. Incorporating JWMS' latest technology, the EXCEL II stent features an abluminal coating of sirolimus combined with an optimized PLA biodegradable polymer, and is deployed from a new delivery system.

Top 100 Global Medical Devices Not Active in India: 2015 Industry Report
M2 - Mon Mar 09, 5:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3gp8dw/global_medical) has announced the addition of the "Global Medical Devices Not Active in India 100: An Industry Report" report to their offering. In India, with a rising population level and higher national growth rates and income levels, the demand for medical devices is expected to grow at a rate of over 15% per year. Though India presents an attractive market opportunity for global medical device manufacturers, the country has never been able to tap into its potential as a domestic manufacturing base. Despite having a medical device market that ranks in the world's top 20, the industry has a long history of being under-resourced. Recently, in a bid to boost investment in the $7 billion medical device sector, the Indian government announced that foreign companies could now fully own existing medical device manufacturers in the country, without the need to get prior approvals. This easing of existing regulations has been done to encourage foreign direct investment since the domestic capital market was not able to provide the much needed investment in this sector. The international companies in this field would now be able to use India as a manufacturing base easily by either setting up facilities of their own or by acquiring domestic manufacturers. FDI inflow will spur R&D and manufacturing innovations, in turn increasing the efficiency and effectiveness of medical electronic products. Advancement of medical electronic product quality and associated successful diagnostic rates are expected to create a spurt in adoption. Report Highlights: - Leading global 100 medical devices companies with no presence in India - Integration of company news and industry news, as well as rankings - Important M&A and alliances among global medical devices companies not active in India - International presence of global medical devices companies not active in India - R&D activities by global medical devices companies not active in India Companies Mentioned - Sample of the Top 100 Companies - A&T Corporation (Japan) - Abaxis Inc(United States) - Abiomed, Inc. (United States) - Advanced Technology Company (Kuwait) - Alphatec Holdings, Inc. (United States) - American Science and Engineering, Inc. (United States) - Atricure, Inc. (United States) - Atrion Corporation (United States) - Austar Lifesciences Ltd (Hong Kong) - Bastide le Confort Medical (France) - Baumer S.A. (Brazil) - Bioquell plc(United Kingdom) - Biosensors International Group Ltd (Singapore) - Canon Electronics Inc.(Japan) - China Medicine Health Industry Co. Ltd(China) - China Renji Medical Group Limited (Hong Kong) - China Resources Wandong Medical Equipment Company Limited (China) - Compumedics Limited (Australia) - Corgenix Medical Corporation(United States) - Create Medic Co., Ltd. (Japan) For more information visit http://www.researchandmarkets.com/research/3g...al_medical
ATEC: 1.37 (+0.06), ABAX: 52.74 (-0.01), ASEI: 39.97 (+0.01)

Biosensors Reports Financial Results for the Third Quarter of Fiscal Year 2015
PR Newswire - Thu Feb 12, 8:42AM CST
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for the third quarter of its Fiscal Year 2015 ("Q3 FY15" and nine months ended 31 December 2014 ("FY15 nine-month period" .

Kevin Sayer Assumes Role of President and Chief Executive Officer; Terry Gregg Transitions to Role of Executive Chairman
Business Wire - Mon Jan 05, 7:31AM CST
DexCom, Inc. (NASDAQ XCM) today announced that Kevin Sayer, currently the Company's President and Chief Operating Officer, has assumed the role of President and Chief Executive Officer to succeed Terry Gregg, who is transitioning to the role of Executive Chairman after more than seven years of service as DexCom's President and Chief Executive Officer.
DXCM: 68.39 (-0.54), SP: 24.40 (-0.03)

Biosensors Reports Financial Results for the Second Quarter and First Half of Fiscal Year 2015
PR Newswire - Wed Nov 12, 5:48AM CST
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for the second quarter of its Fiscal Year 2015 ("Q2 FY15" and first half ended 30 September 2014 ("H1 FY15" .

Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2015
PR Newswire - Wed Aug 06, 7:14AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for its first fiscal quarter ended 30 June 2014 ("Q1 FY15" .

Russia Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Thu Jun 12, 5:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rhvvp7/russia) has announced the addition of the "Russia Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "Russia Interventional Cardiology Market Outlook to 2020", provides key market data on the Russia Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, Russia 4 Overview of Key Companies in Russia, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Medtronic, Inc. - Boston Scientific Corporation - Abbott Laboratories - Cordis Corporation - Terumo Corporation - Biosensors International Group, Ltd. - St. Jude Medical, Inc. - Biotronik SE & Co. KG - Volcano Corporation For more information visit http://www.researchandmarkets.com/research/rhvvp7/russia
BSX: 17.85 (-0.06), ABT: 48.71 (+0.04), MDT: 76.42 (+0.16), VOLC: 17.99 (+0.01), STJ: 74.96 (+0.47)

Mexico Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Thu Jun 12, 5:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8plzfx/mexico) has announced the addition of the "Mexico Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "Mexico Interventional Cardiology Market Outlook to 2020", provides key market data on the Mexico Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, Mexico 4 Overview of Key Companies in Mexico, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Medtronic, Inc. - Boston Scientific Corporation - Abbott Laboratories - Terumo Corporation - Asahi Intecc Co., Ltd. - Volcano Corporation - Cordis Corporation - Merit Medical Systems, Inc. - Biosensors International Group, Ltd. - St. Jude Medical, Inc. For more information visit http://www.researchandmarkets.com/research/8plzfx/mexico
BSX: 17.85 (-0.06), ABT: 48.71 (+0.04), MDT: 76.42 (+0.16), VOLC: 17.99 (+0.01), STJ: 74.96 (+0.47), MMSI: 20.64 (-0.10)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lithium's Next Leg Depends on Storage, Not EV Hype

Updated Category News Views 67

Grid batteries are quietly becoming lithium’s second engine, and that matters more than another flashy electric-vehicle sales headline. The market is projected to rise from $40.87 billion in 2026 to $57.77 billion by 2031, a 7.2% compound annual growth rate. Respectable growth, certainly. But this is not a straight line, and anybody treating a five-year market forecast...

Continue Reading
Travelzoo Turns Thanksgiving Delays Into Member Value

Updated Category News Views 82

Airport gridlock is a miserable place to make a membership pitch, yet Travelzoo has found a pretty shrewd angle for it. On November 18, the company said nearly 20 million travelers will move through airports during the upcoming Thanksgiving holiday, when cancellations and delays can turn an ordinary trip into a long, fluorescent-lit slog. Its offer: qualifying Club...

Continue Reading
CATL Makes Its APEC Case Beyond the Electric Car Market

Updated Category News Views 63

A 99-Second Pitch With Bigger Ambitions Battery swapping got a rare moment in the geopolitical sunlight at Shenzhen's APEC CEO Summit, and CATL was plainly trying to make that moment count. Dr. Robin Zeng, the company's founder, chairman and chief executive, used the opening business dialogue to argue that the Asia-Pacific region holds more opportunity than trouble. Fair...

Continue Reading
Nellie's 50% Booking Jump Reveals a Quieter Luxury

Updated Category News Views 83

Silicon Valley’s rich are apparently tired of performing wealth for strangers, and frankly, that tracks. Nellie’s 2027 forecast says its mostly tech-money clientele is moving past the old trophy case of private jets, famous resort towns, and suites priced like small houses. The prize now is privacy, a clean schedule, and somebody competent fixing the ugly little...

Continue Reading
A Parish Memoir That Sends Its Proceeds Back Home

Updated Category News Views 94

Some books arrive with a thunderclap; this one shows up carrying a folding chair, a prayer book, and a memory that refuses to leave. You Give Them Something to Eat, the new memoir from Fr. Michael J Rieder, is built from more than a hundred short chapters rather than one grand, polished life story. That choice fits the material. Parish life is rarely a clean parade of...

Continue Reading
Haemonetics Opens Europe for VASCADE MVP XL Device

Updated Category News Views 87

A larger collagen plug is hardly cocktail-party material, yet it can matter a great deal when it sits inside a procedure workflow hospitals are trying to speed up. Haemonetics has received CE Mark certification under the EU Medical Device Regulation for VASCADE MVP XL, its larger-bore venous vascular closure system, and first commercial European procedures were completed...

Continue Reading
IIT Madras Maps 100 Brains in a Serious Science Bet

Updated Category News Views 40

A human brain turned into a navigable cellular map is not a flashy launch-day trinket. It is painstaking infrastructure, the kind that can sit quietly for years before researchers figure out what it truly unlocks. That is why the Sudha Gopalakrishnan Brain Centre mission at IIT Madras deserves a serious look rather than the usual chest-thumping over a big scientific...

Continue Reading
BetterInvesting Puts ELMD and FIVE Under a Fresh Lens

Updated Category News Views 30

Two familiar market traps are hiding in this otherwise useful announcement: mistaking a study candidate for a buy signal, and treating the word undervalued like it fell from a mountaintop. BetterInvesting has named Electromed Inc. as its “Stock to Study” and Five Below Inc. as its “Undervalued Stock” for the January-February 2027 issue of its magazine. That is...

Continue Reading
Mar-Jac's Safety Milestone Carries Real Operational Weight

Updated Category News Views 16

Four million worked hours without a lost-time accident is the sort of number that ought to make people pause, especially in poultry processing. Mar-Jac Poultry’s Gainesville facility earned Workplace Safety recognition from the Greater Hall Chamber of Commerce after reaching that mark, and this is one corporate achievement that deserves a little less eye-rolling than...

Continue Reading
Italian Wine Faces U.S. Slump and New Market Openings

Updated Category News Views 110

American demand has put a cork in the easy story, and Italian wine producers cannot pretend otherwise. In the first nine months of 2026, U.S. imports of Italian wine dropped 18.4% by value. That is painful because the United States remains Italy's largest destination market by value, not some side shelf that can be ignored until conditions improve. Still, the broader U.S....

Continue Reading

Top 5 Most Recently Viewed Articles

ChargePoint Faces Share Decline Following Q2 Financial Report

Updated Category News Views 67

Overview of ChargePoint's Stock Performance ChargePoint Holdings Inc (NYSE: CHPT) has seen a drop in its stock value following the release of disappointing financial results for the second quarter. Investors are carefully examining the details of the report, which highlighted significant challenges the company faced during this time. Q2 Financial Highlights In the second...

Continue Reading
Exciting March Madness Audio Coverage by Westwood One 2025

Updated Category News Views 244

Comprehensive Audio Coverage of NCAA Men's Basketball Tournament As the NCAA Men's Basketball Tournament approaches, fans are gearing up for what promises to be an exciting series of games. This year, Cumulus Media's Westwood One (NASDAQ: CMLS) will provide exclusive multiplatform audio coverage of the entire tournament, ensuring that fans can enjoy every moment, whether...

Continue Reading
Cartesian Therapeutics Advances Myasthenia Gravis Treatment Trials

Updated Category News Views 118

Advancements in Myasthenia Gravis Treatment by Cartesian Therapeutics Cartesian Therapeutics, Inc. (NASDAQ: RNAC), a pioneering company in mRNA cell therapy, is making significant strides in developing groundbreaking treatments for autoimmune diseases, especially myasthenia gravis (MG). With encouraging updates from the Phase 2b trial of their leading candidate,...

Continue Reading
Centrifuge Market Set to Surpass $689 Million Amid Growth

Updated Category News Views 147

Growth of the Centrifuge Market: An In-Depth Analysis The centrifuge market is undergoing a remarkable transformation, with projections indicating an increase from USD 463 million in 2023 to an impressive USD 689.91 million by 2032. This growth is driven by a compound annual growth rate (CAGR) of 4.53% from 2024 to 2032, fueled by advancements in biotechnology,...

Continue Reading
National Bank Holdings Sees Price Target Increase by Piper Sandler

Updated Category News Views 58

Piper Sandler Raises Price Target for National Bank Holdings Piper Sandler has recently reviewed its financial outlook for National Bank Holdings (NYSE: NBHC), making a significant update to its price target. The new target has been set at $48.00, an increase from the previous target of $44.00. Current Stock Rating and Rationale The firm has maintained a Neutral rating on...

Continue Reading